Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
SRGAP3 antisense RNA 3 (SRGAP3-AS3) is a long non-coding RNA (lncRNA) gene found in humans and located on chromosome 3 (Ensembl: ENSG00000227929)[3][6][8]. It is transcribed as an antisense RNA overlapping or adjacent to the coding gene SRGAP3 (Slit-Robo Rho GTPase activating protein 3), but unlike SRGAP3, SRGAP3-AS3 is not believed to encode a protein[3][6][9]. Its function remains uncharacterized in published studies, and there is no evidence that it acts as a therapeutic target or is directly implicated in disease pathways[3][5][6][8][9]. No drugs or inhibitors are currently known or reported to interact with this RNA, nor is it described as a biomarker or a source of specific therapeutic or safety concerns in the literature[5][6][9]. While the protein-coding SRGAP3 gene has roles in neuronal signaling and neurodevelopment[1], the biological function of its antisense RNA counterpart, SRGAP3-AS3, remains unclear and is a subject for further research[5][9].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on SRGAP3 antisense RNA 3 (SRGAP3-AS3).